共 50 条
- [2] Treating Rheumatoid Arthritis to Target: Outcomes and Predictors in Early Rheumatoid Arthritis Patients Treated with Adalimumab Plus Methotrexate, Methotrexate Alone, or Methotrexate Plus Subsequent Adalimumab [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S665 - S665
- [4] Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (11) : 1566 - 1572
- [5] Comparative efficacy and safety of adalimumab biosimilars and adalimumab in patients with rheumatoid arthritis presenting an insufficient response to methotrexate: a network meta-analysis [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2023, 82 (01): : 64 - 70